Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
批准号:
8730697
负责人:
Kirk P Conrad
金额:
$122.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-27 至 2016-02-29
关键词:
AddressAgeAssisted Reproductive TechnologyBiostatistics CoreBone MarrowBudgetsCardiovascular systemCerebrumClinicalClinical ResearchComorbidityConceptionsDatabasesEpidemiologyExclusion CriteriaFloridaFutureHormonesHuman ResourcesInvestigationKidneyKnowledgeMaternal AgeMaternal PhysiologyMetabolicMorbidity - disease rateMothersOutcomePerinatalPhysiologicalPhysiological AdaptationPhysiologyPregnancyPregnancy OutcomePrimatesProductionProtocols documentationPublished CommentRecruitment ActivityRelaxationRelaxinReproductive PhysiologyResearchRoleSecondary toSocietiesStem cellsStructureTestingTimeTranslationsUniversitiesVascular DiseasesVasodilationWomanangiogenesisbaseclinical practicecorpus luteumdata managementdesignegghypertensive heart diseaseimprovedinsightmortalitynovelolder womenpatient populationperinatal outcomespreclinical studyprogramsprospectiveresponsesynergism
中文摘要
描述(由申请人提供):本项目的总体假设是,许多通过辅助生殖技术(ART)怀孕的孕妇开始于一种对母亲来说不是生理性的状态,其次是黄体及其松弛素或其他激素产生的异常状态。因此,黄体、母体循环松弛素和其他黄体激素可能完全缺失,或者根据ART方案可能存在多个黄体、松弛素和其他黄体激素的超生理浓度。无论是自然发生的还是医源性的,我们认为异常的黄体状态损害了母体对妊娠的最佳生理适应,因此,容易发生产科并发症和不良的围产期结局。这一假设是建立在我们临床前和临床研究的诱人和挑衅,但令人信服的初步证据之上的。在项目一中,我们将首次全面调查佛罗里达大学CTSI孕妇对ART妊娠的心血管适应性。在项目II中,将在ART受试者中探索一种新的令人兴奋的母体对妊娠的适应,涉及骨髓来源的祖细胞,以及母体血管舒张,动脉顺应性增加,内皮依赖性松弛和母体血管生成。在项目III中,我们将利用辅助生殖技术协会(SART)数据库和斯坦福大学辅助生殖技术患者群体的前瞻性分析,探讨黄体状态是否与产科并发症增加、围产期发病率和死亡率相关。这3个项目将由3个核心组成:行政核心A,数据管理和生物统计核心B和分析核心c。在组成项目和核心之间有许多智力和后勤互动和强有力的协同作用。
英文摘要
DESCRIPTION (provided by applicant): The overarcliing hypothesis of this Program Project is that many pregnancies conceived by ART (Assisted Reproductive Technology) begin in a state which is not physiological for the mother, secondary to the abnormal status of the corpus luteum and its production of relaxin or other hormones. Thus, the corpus luteum, maternal circulating relaxin and other corpus luteal hormones may be absent altogether, or there may be multiple corpora lutea, supraphysiological concentrations of relaxin and other corpus luteal hormones depending on the ART protocol. Whether naturally occuring or iatrogenically imposed, we propose that abnormal corpus luteal status compromises optimal maternal physiological adaptations to pregnancy, and consequently, predisposes to obstetrical complications and adverse perinatal outcomes. This hypothesis is founded upon tantalizing and provocative, yet compelling preliminary evidence from our preclinical and clinical studies. In Project I, we will comprehensively investigate for the first time, the maternal cardiovascular adaptations to ART pregnancies in the University of Florida CTSI. In Project II, a new and exciting maternal adaptation to pregnancy dealing with bone marrow derived progenitor cells will be explored in ART subjects, and in relation to maternal vasodilation, increases in arterial compliance, endothelial dependent relaxation and maternal angiogenesis. In Project III, we will interrogate whether the state of the corpus luteum correlates with increased obstetrical complications, and perinatal morbidity and mortality using the Society of Assisted Reproductive Technology (SART) database, and prospective analysis of the Stanford ART patient populations. These 3 Projects will be joined by 3 Cores: Administrative Core A, Data Management and Biostatistics Core B, and Analytical Core C. There are numerous intellectual and logistical interactions and potent synergisms among the component Projects and Cores.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
-
批准号:8337222
-
项目类别:
-
资助金额:$121.26万
-
财政年份:2011
-
负责人:Kirk P Conrad
-
依托单位:
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
-
批准号:8509741
-
项目类别:
-
资助金额:$116.83万
-
财政年份:2011
-
负责人:Kirk P Conrad
-
依托单位:
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
-
批准号:8151717
-
项目类别:
-
资助金额:$125.48万
-
财政年份:2011
-
负责人:Kirk P Conrad
-
依托单位:
Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in ART
-
批准号:9058150
-
项目类别:
-
资助金额:$125.61万
-
财政年份:2011
-
负责人:Kirk P Conrad
-
依托单位:
Mechanisms of Renal Vasodilation by Relaxin
-
批准号:7738676
-
项目类别:
-
资助金额:$23.66万
-
财政年份:2009
-
负责人:Kirk P Conrad
-
依托单位:
Mechanisms of Renal Vasodilation by Relaxin
-
批准号:7895648
-
项目类别:
-
资助金额:$18.66万
-
财政年份:2009
-
负责人:Kirk P Conrad
-
依托单位:
Relaxin: The 'Elusive' Vasodilator of Pregnancy
-
批准号:6703795
-
项目类别:
-
资助金额:$0.84万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Endogenous Relaxin Regulates Vascular Function in Nonpregnant Females and Males
-
批准号:7388841
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Endogenous Relaxin Regulates Vascular Function in Nonpregnant Females and Males
-
批准号:7252878
-
项目类别:
-
资助金额:$39.36万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
PLACENTAL CYTOKINES AND PATHOGENESIS OF PREECLAMPSIA
-
批准号:6410480
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Relaxin: The 'Elusive' Vasodilator of Pregnancy
-
批准号:6527772
-
项目类别:
-
资助金额:$22.52万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Endogenous Relaxin Regulates Vascular Function in Nonpregnant Females and Males
-
批准号:7224148
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Endogenous Relaxin Regulates Vascular Function in Nonpregnant Females and Males
-
批准号:7588760
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Relaxin: The 'Elusive' Vasodilator of Pregnancy
-
批准号:6364808
-
项目类别:
-
资助金额:$27.62万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
Relaxin: The 'Elusive' Vasodilator of Pregnancy
-
批准号:6637316
-
项目类别:
-
资助金额:$22.76万
-
财政年份:2001
-
负责人:Kirk P Conrad
-
依托单位:
PLACENTAL CYTOKINES AND PATHOGENESIS OF PREECLAMPSIA
-
批准号:6395947
-
项目类别:
-
资助金额:$18.87万
-
财政年份:2000
-
负责人:Kirk P Conrad
-
依托单位:
PLACENTAL CYTOKINES AND PATHOGENESIS OF PREECLAMPSIA
-
批准号:6108695
-
项目类别:
-
资助金额:$18.87万
-
财政年份:1999
-
负责人:Kirk P Conrad
-
依托单位:
PLACENTAL CYTOKINES AND PATHOGENESIS OF PREECLAMPSIA
-
批准号:6296785
-
项目类别:
-
资助金额:$18.87万
-
财政年份:1999
-
负责人:Kirk P Conrad
-
依托单位:
PLACENTAL CYTOKINES AND PATHOGENESIS OF PREECLAMPSIA
-
批准号:6272274
-
项目类别:
-
资助金额:$18.15万
-
财政年份:1998
-
负责人:Kirk P Conrad
-
依托单位:
MECHANISMS OF VASODILATION IN PREGNANCY
-
批准号:2889083
-
项目类别:
-
资助金额:$19.14万
-
财政年份:1998
-
负责人:Kirk P Conrad
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: